Top-News

CAC 40 Index

Index
WKN:  969400 ISIN:  FR0003500008
8.097,85
-0,51%
-41,3599
16:50:28 Uhr
Depot/Watchlist
Weiter abwärts? Short handeln - Jetzt mit Hebel 14,67: MG3MY2
Werbung

Ad-hocs

23.06.25 - GlobeNewswire
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
Sarclisa recommended for EU approval by the CHMP to treat transplant-​eligible newly diagnosed multiple myeloma
20.06.25 - GlobeNewswire
ArcelorMittal announces sale of Bosnian operations
20 June 2025, 15:30 CET
20.06.25 - GlobeNewswire
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
18.06.25 - GlobeNewswire
ArcelorMittal completes the acquisition of Nippon Steel Corporation’s interest in AM/NS Calvert
18 June 2025, 19:30 CET
18.06.25 - EQS
EQS-Adhoc: Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025
EQS-​Ad-hoc: Airbus SE / Key word(s): Forecast Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025 18-Jun-2025 / ...
17.06.25 - GlobeNewswire
Press release: Sanofi successfully prices €1.5 billion bond issue
Sanofi successfully prices €1.5 billion bond issue
15.06.25 - GlobeNewswire
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-​ever presented phase 4 ...
09.06.25 - GlobeNewswire
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus ...
05.06.25 - GlobeNewswire
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
Sanofi Launches 2025 Global Employee Stock Purchase Plan
03.06.25 - GlobeNewswire
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
ASCO: new Sarclisa data support subcutaneous administration with on-body injector
03.06.25 - GlobeNewswire
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, ...
30.05.25 - GlobeNewswire
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe ...
29.05.25 - GlobeNewswire
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Beyfortus public health advantage bolstered by first real-​world comparison of infant vs maternal RSV immunization programs Late-​breaking data show infant respiratory syncytial ...
27.05.25 - GlobeNewswire
Press Release: Sanofi completes acquisition of DR-0201
Sanofi completes acquisition of DR-0201
22.05.25 - GlobeNewswire
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today ...
06.05.25 - GlobeNewswire
Capgemini confirms its ESG commitment with an updated policy and enhanced objectives
Press contact: Sereydana Oum Tel.: +33 6 61 42 03 59 E-mail: sereydana.oum@capgemini.com
06.05.25 - GlobeNewswire
ArcelorMittal announces results of its General Meeting
6 May 2025, 15.15 CET
30.04.25 - GlobeNewswire
Press Release: Annual General Meeting of April 30, 2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, ...
30.04.25 - EQS
EQS-Adhoc: Airbus SE: Airbus reports First Quarter (Q1) 2025 results
EQS-​Ad-hoc: Airbus SE / Key word(s): Quarter Results Airbus SE: Airbus reports First Quarter (Q1) 2025 results 30-Apr-2025 / 17:35 CET/CEST Disclosure of an inside information ...
30.04.25 - GlobeNewswire
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Sanofi and CD&R close Opella transaction, creat e global consumer healthcare leader Paris, April 30, 2025 . Opella today becomes an independent global leader in consumer ...

Newssuche

Videos

newspaper
16:00 Uhr -2,02%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »